NewAmsterdam Pharma Company N.V. Ordinary Shares Capital Reinvestment Ratio
NewAmsterdam Pharma Company N.V. Ordinary Shares capital reinvestment ratio. NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Capital Reinvestment Ratio of 0.00x as of December 2022, meaning it reinvests 0% of its operating cash flow ($29.19 Million) in capital expenditures ($109.43K). Check NAMS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)
Capital reinvestment ratio of NewAmsterdam Pharma Company N.V. Ordinary Shares from 2022 to 2022. This chart tracks NewAmsterdam Pharma Company N.V. Ordinary Shares's Capital Reinvestment Ratio across 1 annual periods. Also explore NAMS shareholders equity momentum to track the company's year-over-year net asset growth rate.
NewAmsterdam Pharma Company N.V. Ordinary Shares Capital Reinvestment Ratio by Year (2022–2022)
NewAmsterdam Pharma Company N.V. Ordinary Shares capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see NAMS operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.02x | $10.66 Million | $221.00K | — |